1887

Abstract

SUMMARY

The present study demonstrates that subcutaneous injection of purified adenovirus 12 fibre protein (FP) to 4-week-old Balb/c mice, 4, 2 and 1 day(s) before intramuscular injection of murine sarcoma virus (MSV-M) or 2 and 1 day before and 1 day after MSV-M injection causes significant inhibition of tumour growth ( < 0.001). The evidence suggests that treatment with FP leading to tumour inhibition is due to neither an interferon mechanism nor to inhibition of virus multiplication by FP in the reticuloendothelial system. It is postulated that immune functions, probably directed against MSV-induced cell antigens, might be the critical mechanisms underlying inhibition of tumour growth.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-52-2-377
1981-02-01
2024-05-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/52/2/JV0520020377.html?itemId=/content/journal/jgv/10.1099/0022-1317-52-2-377&mimeType=html&fmt=ahah

References

  1. Abid S. H., Khoobyarian N. 1976a; Inhibition of murine sarcoma virus induced transformations by adenovirus structural proteins. Journal of General Virology 31:437–446
    [Google Scholar]
  2. Abid S. H., Khoobyarian N. 1976b; Antitumour activity of adenovirus 12 structural proteins against Moloney sarcoma tumours in mice. British Journal of Cancer 33:385–391
    [Google Scholar]
  3. Blumenschein C. R., Moloney J. B. 1969; Quantitative dose response relationship of murine sarcoma virus (Moloney) in BALB/c mice. Journal of the National Cancer Institute 42:123–133
    [Google Scholar]
  4. Long W. K. Jr, Khoobyarian N. 1973; Effect of adenovirus soluble antigens on virus synthesis and transformations in diploid cells. Journal of the National Cancer Institute 51:1527–1533
    [Google Scholar]
  5. Perk K., Moloney J. B. 1966; Pathogenesis of Moloney virus-induced rhabdomyosarcoma in mice. Journal of the National Cancer Institute 37:581–599
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-52-2-377
Loading
/content/journal/jgv/10.1099/0022-1317-52-2-377
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error